SpecialtiesQuestion

Do you taper or stop avacopan in patients with ANCA-associated vasculitis once remission is achieved?

2

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you differentiate fibromuscular dysplasia from PAN / abdominal vasculitis?

Have you seen microscopic polyangiitis associated with temporal artery involvement?

Can cryoglobulins be present in the setting of severe acrocyanosis without evidence of active cryoglobulinemic vasculitis?

Has the January 2026 FDA-requested voluntary withdrawal of avacopan, citing concerns about clinical trial data and potential safety risks, changed your prescribing practices?

For patients with definite UIP and MPO-ANCA-associated vasculitis limited to the lungs (without systemic manifestations), what is the role of immunosuppression?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.